Yi Xiang Zhou
Direktor/Vorstandsmitglied bei Shanghai Xinchuan Investment Management Co. Ltd.
Aktive Positionen von Yi Xiang Zhou
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Shanghai Xinchuan Investment Management Co. Ltd.
Shanghai Xinchuan Investment Management Co. Ltd. Financial ConglomeratesFinance Part of Shanghai Origincell Biological Cryo Equipment Co. Ltd., Shanghai Xinchuan Investment Management Co. Ltd. provides investment and investment management services. The company is based in Shanghai, China. Shanghai Xinchuan Investment Management Co. was founded in 2011. Shanghai Xinchuan Investment Management Co. was acquired by Lishui Yuanxin Industry Development Co. Ltd. from Canature Health Technology Group Co., Ltd. on December 28, 2021 for $27.42 million. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Yi Xiang Zhou
Ehemalige bekannte Positionen von Yi Xiang Zhou
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CANATURE HEALTH TECHNOLOGY CO., LTD. | Direktor/Vorstandsmitglied | 01.01.2003 | - |
Ausbildung von Yi Xiang Zhou
Shanghai Open University | Undergraduate Degree |
Statistik
International
China | 4 |
Operativ
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sektoral
Producer Manufacturing | 2 |
Consumer Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CANATURE HEALTH TECHNOLOGY CO., LTD. | Producer Manufacturing |
Private Unternehmen | 1 |
---|---|
Shanghai Xinchuan Investment Management Co. Ltd.
Shanghai Xinchuan Investment Management Co. Ltd. Financial ConglomeratesFinance Part of Shanghai Origincell Biological Cryo Equipment Co. Ltd., Shanghai Xinchuan Investment Management Co. Ltd. provides investment and investment management services. The company is based in Shanghai, China. Shanghai Xinchuan Investment Management Co. was founded in 2011. Shanghai Xinchuan Investment Management Co. was acquired by Lishui Yuanxin Industry Development Co. Ltd. from Canature Health Technology Group Co., Ltd. on December 28, 2021 for $27.42 million. | Finance |
- Börse
- Insiders
- Yi Xiang Zhou
- Erfahrung